Home
Conditions
Myeloma

Clinical trial condition

Myeloma

Explore clinical trials studying Myeloma. Study availability and eligibility vary by location and protocol.

115 public trials 23 recruiting studies

Refine in advanced search Browse all conditions

Myeloma trial results

Completed

Nivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide

NCT03184194

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: Rijnstate ziekenhuis Arnhem, Ge, Netherlands

Radboud MC Nijmegen, Ge, Netherlands

MUMC Maastricht, Li, Netherlands

VU University Medical Center Amsterdam, North Holland, Netherlands

View Trial Details

Completed

The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures

NCT06153576

Conditions: Bone Metastases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: CHU NICE Nice, Alpes Maritimes, France

View Trial Details

Completed

Evaluation of the Success of Prophylactic Enteral Nutrition in Therapeutic Intensification With Autograft of Autologous Hematopoietic Cells in Hematology

NCT04703985

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: CH de la Côte Basque Bayonne, France

CHU Bordeaux Bordeaux, France

View Trial Details

Completed

Pedometer Activity Monitoring After ASCT

NCT03238599

Conditions: Autologous Stem Cell Transplantation, Hemic and Lymphatic Diseases, High-dose Chemotherapy, +9 more
Locations: Departement of Medical Oncology, University Hospital Berne Bern, Switzerland

View Trial Details

Completed

Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer

NCT00001582

Conditions: ATL, Autoimmune Diseases, B-cell Lymphoma, +14 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis

NCT02593123

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +45 more
Locations: Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Imageguided Theranostics in Multiple Myeloma

NCT02403102

Conditions: Cancer, Myeloma, Neoplasms, +2 more
Locations: The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom

View Trial Details

Completed

Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma

NCT01793051

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

NCT00907452

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: CH ALBI Albi, France

CHRU Angers Angers, France

CH Côte basque Bayonne, France

CH Blois Blois, France

View all 26 locations

View Trial Details

Completed

Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients

NCT00469209

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Myeloma

Myeloma trial results

Related conditions